Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats

Journal of Bone and Mineral Metabolism

Volumn 26, Issue 4, 2008, Pages 342-349

  Dai, Ruchun ^a   Ma, Yulin ^a   Sheng, Zhifeng ^a   Jin, Yan ^a   Zhang, Yuhai ^a   Fang, Lingna ^a   Fan, Huijie ^a   Liao, Eryuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Biomechanics; Genistein; Microcrack; Microstructure; Osteocyte density

Indexed keywords

ESTRADIOL; FUCHSINE; GENISTEIN; METHACRYLIC ACID METHYL ESTER;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE; BONE DENSITY; BONE MINERALIZATION; BONE STRENGTH; BONE STRUCTURE; COMPRESSION; CONTROLLED STUDY; DRUG EFFECT; FATIGUE; FEMALE; HORMONE SUBSTITUTION; LUMBAR VERTEBRA; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOCYTE; OSTEOPOROSIS; OVARIECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; STAINING; TRABECULAR BONE; ULTRASTRUCTURE;

ANIMALS; BIOMECHANICS; BONE DENSITY; CELL COUNT; FEMALE; GENISTEIN; OSTEOCYTES; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL FRACTURES; SPINE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 46849116642     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-007-0830-4     Document Type: Article

References (62)

1. Cosman F, Lindsay R (1999) Selective estrogen receptor modulators: clinical spectrum. Endocr Rev 20:418-434
2. Setchell KDR (2001) Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulator (SERMs). J Am Coll Nutr 20:S 354-362
3. Brezinski A, Debi A (1999) Phytoestrogens: the "natural" selective estrogen receptor modulators. Eur J Obstet Gynecol Reprod Biol 85:47-51
4. Blair HC, Jordan SE, Peterson TG Barnes S (1996) Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 61:629-637
5. Ishimi Y, Miyaura C, Ohmura M, Onoe Y, Sato T, Uchiyama Y, Ito M, Wang X, Suda T, Ikegami S (1999) Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140:1893-1900
6. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JWJ (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: S1375-1379
7. Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R, Strauss BJ (1998) Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1:124-129
8. Ho SC, Chan SG, Yi Q, Wong E, Leung PC (2001) Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 16:1363-1369
9. Gallagher JC, Rafferty K, Haynatzka V, Wilson M (2000) Effects of soy protein on bone metabolism. J Nutr 130:S667
10. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewica-Sapuntzakis M, Gou P (1996) Dietary soy protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161-167
11. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC (1998) Bone-sparing effect of soy protein in ovarian hormone deficient rats is related to its isoflavone content. Am J Clin Nutr 68:S 1364-1368
12. Picherit C, Chanteranne B, Bennetau-Pelissero C, Davicco MJ, Lebecque P, Barlet JP, Coxam V (2001) Dose-dependent bonesparing effects of dietary isoflavones in the ovariectomized rat. Br J Nutr 85:307-316
13. Majumdar S, Kothari M, Augat P, Newitt DC, Link TM, Lin JC, Lang T, Lu Y, Genant HK (1998) High resolution magnetic resonance imaging: three-dimensional trabecular bone architecture and biomechanical properties. Bone (NY) 22:445-454
14. Ammann P, Rizzoli R (2003) Bone strength and its determinants. Osteoporos Int 14:S13-S18
15. Delmas PD, Seeman E (2004) Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone (NY) 34:599-604
16. Allen MR, Iwata K, Sato M, Burr DB (2006) Raloxifene enhances vertebral mechanical properties independent of bone density. Bone (NY) 39:1130-1135
17. Seeman E (2001) Clinical review 137: sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 86: 4576-4584
18. Compston J (2006) Bone quality: what is it and how is it measured? Arq Bras Endocrinol Metab 50:579-585
19. Dai RC, Liao EY, Yang C, W XP, Jiang Y (2004) Microcracks: an alternative index for evaluating bone biomechanical quality. J Bone Miner Metab 22:215-223
20. Frank JD, Ryan M, Kalscheur VL, Ruaux-Mason CP, Hozak RR, Muir P (2002) Aging and accumulation of microdamage in canine bone. Bone (NY) 30:201-206
21. Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH (1998) The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 8:274-281
22. Bouali Y, Gaillard-Kelly M, Marie PJ (2001) Effect of trimegestone alone or in combination with estradiol on bone mass and bone turnover in an adult rat model of osteopenia. Gynecol Endocrinol 15:48-55
23. Hott M, de Pollak C, Modrowski D, Marie PJ (1993) Short-term effects of organic silicon on trabecular bone in mature ovariectomized rats. Calcif Tissue Int 53:174-179
24. Modder UI, Riggs BL, Spelsberg TC, Fraser DG, Atkinson EJ, Arnold R, Khosla S (2004) Dose-response of estrogen on bone versus the uterus in ovariectomized mice. Eur J Endocrinol 151:503-510
25. Peng WJ, Jiang JL, Jia SJ, Li D, Zhang XJ, Luo D, Liao EY, Deng HW, Li YJ (2005) Asymmetric dimethylarginine is not involved in ovariectomy-induced osteopenia in rats. Comp Med 55:30-33
26. Yamamoto Y, Kurabayashi T, Tojo Y, Yahata T, Honda A, Tomita M, Tanaka K (1998) Effects of progestins on the metabolism of cancellous bone in aged oophorectomized rats. Bone (NY) 22:533-537
27. Sheng Z, Dai R, Wu X, Fang L, Fan H, Liao E (2007) Regionally specific compensation for bone loss in the tibial trabeculae of estrogen-deficient rats. Acta Radiol 48:531-539
28. Burr DB, M Hooser (1995) Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo. Bone (NY) 17:431-433
29. Da Costa Go'mez TM, Barrett JG, Sample SJ, Radtke CL, Kalscheur VL, Lu Y, Markel MD, Santschi EM, Scollay MC, Muir P (2005) Up-regulation of site-specific remodeling without accumulation of microcracking and loss of osteocytes. Bone (NY) 37:3716-3724
30. Hapidin H, Othman F, Soelaiman IN, Shuid AN, Luke DA, Mohamed N (2007) Negative effects of nicotine on bone-resorbing cytokines and bone histomorphometric parameters in male rats. J Bone Miner Metab 25:93-98
31. Hotchkiss CE, Weis C, Blaydes B, Newbold R, Delclos KB (2005) Multigenerational exposure to genistein does not increase bone mineral density in rats. Bone (NY) 37:720-727
32. Anderson JJB, Ambrose WW, Garner SC (1998) Biphasic effects of genistein on bone tissue in the ovariectomized lactating rat model. Proc Soc Exp Biol Med 217:345-350
33. Hertrampfa T, Grucaa MJ, Seibela J, Laudenbacha U, Fritzemeierb KH, Diela P (2007) The bone-protective effect of the phytoestrogen genistein is mediated via ERá-dependent mechanisms and strongly enhanced by physical activity. Bone (NY) 440:1529-1535
34. Picherit C, Bennetau-Pelissero C, Chanteranne B, Lebecque P, Davicco MJ, Barlet JP, Coxam V (2001) Soybean isoflavones dose dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131: 723-728
35. Draper CR, Edel MJ, Dick IM, Randall AG, Martin GB, Prince RL (1997) Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J Nutr 127:1795-1799
36. Register TC, Jayo MJ, Anthony MS (2003) Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys. J Clin Endocrinol Metab 88:4362-4370
37. Lees CJ, Ginn TA (1998) Soy protein isolate does not prevent increased cortical bone turnover in ovariectomized macaques. Calcif Tissue Int 62:557-558
38. Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N, Lubrano C, Bonaiuto M, D'Anna R, Cannata ML, Corrado F, Adamo EB, Wilson S, Squadrito F (2007) Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 146:839-847
39. Mei J, Yeung SSC, Kung AWC (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86:5217-5221
40. Wang ZL, Sun JY, Wang DN, Xie YH, Wang SW, Zhao WM (2006) Pharmacological studies of the large-scaled purified genistein from Huaijiao (Sophora japonica-Leguminosae) on antiosteoporosis. Phytomedicine 13:718-723
41. Weaver CM, Cheong JMK (2005) Soy isoflavone and bone health: the relationship is still unclear. J Nutr 135:1243-1247
42. Hao YJ, Tang Y, Chen FB, Pei FX (2005) Different doses of nitric oxide donor prevent osteoporosis in ovariectomized rats. Clin Orthop Relat Res 435:226-231
43. Kawane T, Terashima S, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N (2004) Atorvastatin enhances bone density in ovariectomized rats given 17beta-estradiol or human parathyroid hormone(1-34). Endocrine 24:121-129
44. Hernandez CJ, Majeska RJ, Schaffler MB (2004) Osteocyte density in woven bone. Bone (NY) 35:1095-1099
45. Ireland DC, Bord S, Beavan SR, Compston GE (2002) Effects of estrogen on collagen synthesis by cultured human osteoblasts depend on the rate of cellular differentiation. J Cell Biochem 86:251-257
46. Zaman G, Jessop HL, Muzylak M, De Souza RL, Pitsillides AA, Price JS, Lanyon LL (2006) Osteocytes use estrogen receptor á to respond to strain but their ERá content is regulated by estrogen. J Bone Miner Res 21:1297-1306
47. Tomkinson A, Gevers EF, Wit JM, Reeve J, Noble BS (1998) The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res 13:1243-1250
48. Ren P, Ji H, Sao Q, Chen X, Han J, Sun Y (2007) Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats. Pharmacology 79:129-136
49. Boyce RW, Ebert DC, Youngs TA, Paddock CL, Mosekilde L, Stevens ML, Gundersen HJ (1995) Unbiased estimation of vertebral trabecular connectivity in calcium-restricted ovariectomized mini-pigs. Bone (NY) 16:637-642
50. Waarsing JH, Day JS, van der Linden JC, Ederveen AG, Spanjers C, De Clerck N, Sasov A, Verhaar JA, Weinans H (2004) Detecting and tracking local changes in the tibiae of individual rats: a novel method to analyse longitudinal in vivo micro-CT data. Bone (NY) 34:163-169
51. Chen P, Jerome CP, Burr DB, Turner CH, Ma YL, Rana A, Sato M (2007) Interrelationships between bone microarchitecture and strength in ovariectomized monkeys treated with teriparatide. J Bone Miner Res 22:841-848
52. Ulrich D, van Rietbergen B, Laib A, Ruegsegger P (1999) The ability of three dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone (NY) 25:55-60
53. Muller R, Hannan M, Smith SY, Bauss F (2004) Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey. J Bone Miner Res 19:1787-1796
54. Lane NE, Kumer JL, Majumdar S, Khan M, Lotz J, Stevens RE, Klein R, Phelps KV (2002) The effects of synthetic conjugated estrogens, a (cenestin) on trabecular bone structure and strength in the ovariectomized rat model. Osteoporos Int 13: 816-823
55. Allen MR, Hogan HA, Hobbs WA, Koivuniemi AS, Koivuniemi MC, Burr DB (2007) Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone. Endocrinology 148:3908-3913
56. Tromp AM, Bravenboer N, Tanck E, Oostlander A, Holzmann PJ, Kostense PJ, Roos JC, Burger EH, Huiskes R, Lips P (2006) Additional weight bearing during exercise and estrogen in the rat: the effect on bone mass, turnover, and structure. Calcif Tissue Int 79:404-415
57. Ma YL, Bryant HU, Zeng Q, Schmidt A, Hoover J, Cole HW, Yao W, Jee WS, Sato M (2003) New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats. Endocrinology 144:2008-2015
58. Qiu S, Rao DS, Palnitrar S, Parfitt AM (2003) Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture. J Bone Miner Res 18:1657-1663
59. Parfitt AM, Villanueva AR, Foldes J, Rao DS (1995) Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res 10:466-473
60. Taylor D (1997) Bone maintenance and remodeling: a control system based on fatigue damage. J Orthop Res 15:601-606
61. O'Brien CA, Jia D, Plotkin LI (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835-1841
62. Schaffler MB, Majeska RJ (2005) Role of the osteocyte in mechanotransduction and skeletal fragility. In: Proceedings of the NIAMS-ASBMR scientific meeting: Bone quality: what is it and can we measure it? Bethesda, MD, May 2-3 (abstract)